Clinical Trial Update: Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of a farnesyl protein transferase inhibitor in combination with gemcitabine and cisplatin in patients with advanced cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Farnesyl Protein Transferase Inhibitor (farnesyltransferase inhibitor)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms | Phase 1 | Status: TERMINATED